LUTZ, Fla.--(BUSINESS WIRE)-- CytoDyn Inc. (the “Company”) (OTC:CYDY), a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, ...

Akeso, Inc. (9926.HK) announced that its supplemental New Drug Application (sNDA) for gumokimab (AK111), a novel humanized anti-IL-17A monoclonal antibody for the treatment of active ankylosing ...

Antibody humanization involves modifying antibodies from non-human sources, such as mice, to decrease their immunogenicity in human applications. While mouse monoclonal antibodies are specific, they ...

In therapeutic applications, monoclonal antibodies (mAbs) provide highly precise targeting of pathological cells and reduced side effects in treating disease. Experimental mice are widely used models ...

DUBLIN--(BUSINESS WIRE)--The "Global Therapeutic Antibody Market (2023 Edition): Analysis By Antibody Type (Monoclonal, Bispecific, Drug Conjugates, Others), Source (Fully human, Humanized, Others), ...

NMPA accepts Akeso’s supplemental New Drug Application for gumokimab to treat active ankylosing spondylitis: Hong Kong Wednesday, January 21, 2026, 12:00 Hrs [IST] Akeso Inc, a ...

Epitomics, Inc. today announced that it has spun-out to its shareholders a new biotechnology company called Apexigen, Inc., which will focus on the development and commercialization of humanized ...

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...

In the aftermath of those cases, some practitioners have suggested means-plus-function claiming as one strategy to obtain antibody claims that are broader in scope than the specific antibodies ...

Chemotherapy is one of the most widely used cancer therapies; however, chemotherapy often causes serious side effects. Antibody-drug conjugates (ADCs) are promising emergent cancer therapies that ...

The "Engineered Antibody Therapeutics for Cancer" report has been added to ResearchAndMarkets.com's offering. This study analyzes the emergence of engineered antibody therapeutics for cancer, ...

There are over 60 different therapeutic monoclonal antibodies approved by the FDA; treating a variety of diseases, including solid-organ tumors, hematological malignancies, rheumatological disorders, ...